The present study aimed to validate and compare the predictive accuracies of the Memorial Sloan Kettering Cancer Center (MSKCC) and Johns Hopkins University (JHU) web-based postoperative nomograms for predicting early biochemical recurrence (BCR) after radical prostatectomy (RP) and to analyze clinicopathological factors to predict early BCR after RP using our dataset. The c-index was 0.72 (95% confidence (CI): 0.61-0.83) for the MSKCC nomogram and 0.71 (95% CI: 0.61-0.81) for the and JHU nomogram, demonstrating fair performance in the Japanese population. Furthermore, we statistically analyzed our 174 patients to elucidate prognostic factors for early BCR within 2 years. Lymphovascular invasion (LVI) including lymphatic vessel invasion (ly) was a significant predictor of early BCR in addition to common variables (pT stage, extraprostatic extension, positive surgical margin and seminal vesicle invasion). LVI, particularly ly, may provide a good predictor of early BCR after RP and improve the accuracy of the nomograms.
Introduction
Prostate cancer (PC) is the most frequently diagnosed malignancy among males in both Japan and Western countries (1, 2) . Radical prostatectomy (RP) represents the standard treatment for localized PC (3, 4) . However,~25% of all patients undergoing RP experience biochemical recurrence (BCR) and require secondary treatments. In addition,~77% of BCR occurs early during first 2 years after RP (5, 6) . Unfortunately, patients who experience BCR within 2 years after RP show poorer metastasis-free survival as compared with patients with more than 2 years (7). Freedland and colleagues reported that the 15-year actuarial PC-specific survival rate after BCR in patients with recurrence at ≤3 years was 41%, compared to 87% in patients with recurrence at >3 years after RP (8) . Moreover, they also showed that a shorter time from RP to BCR was associated with increased risk of death due to PC (8) .
Predicting the probability of early BCR after RP is thus extremely important to clinical practice, because tighter follow-up or more aggressive therapeutic intervention might be warranted in patients at greater risk of early BCR after RP. Some trials showed that adjuvant radiation therapy decreased BCR (9) (10) (11) (12) . Although several nomograms predicting the probability of early BCR after RP have been reported (5, 8, 13, 14) , only two nomograms appear to be accessible from the web (15, 16) . One is the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram, which predicts the probability of remaining recurrence-free at 2, 5, 7 and 10 years following surgery (15) . The other is the Johns Hopkins University (JHU) nomogram, which predicts the probability of BCR at 3, 5, 7 and 10 years following surgery (16) . Although each nomograms is not widely used in daily practice, such web-based nomograms are very convenient and user-friendly for both clinicians and patients, allowing access all over the world. However, major problems are seen from the perspective of the predictive accuracy of each nomogram, because clinical and biological differences in PC are seen according to ethnicity and medical environments in individual countries (17, 18) .
The present study aimed to validate and compare the predictive accuracies of the MSKCC and JHU nomograms on the web. In addition, we analyzed clinical variables including age, preoperative concentration of prostate-specific antigen (PSA) and pathological findings to predict early BCR within 2 years after RP using our dataset.
Patients and methods
This retrospective study was approved by the institutional review board (S17042). A total of 233 patients who underwent RP for prostate cancer were seen at Toho University Sakura Medical Center between May 2010 and December 2014. All RP was carried out by open surgery. Seventeen patients were excluded from the present study for the following reasons: androgen deprivation therapy (ADT) performed before the operation in six patients; ADT started immediately after RP in 10 patients; and no malignancy found in the surgical specimen in one patient. Moreover, we excluded cases with missing values of MSKCC nomogram or less than 2 years after RP, and cases with missing values of JHU nomogram or less than 3 years after RP. Eventually, 174 patients were statistically analyzed for the MSKCC nomogram and 160 patients for the JHU nomogram in the present study.
Medical records were surveyed retrospectively, and the following data were collected from the medical charts: PSA value before RP; pathological Gleason score (GS); pathological T stage; resection margin (RM); extraprostatic extension (EPE); lymphatic vessel invasion (ly); vascular invasion (v); lymphovascular invasion (LVI), defined as the presence of cancer cells within any arterial, venous, or lymphatic lumen on routine hematoxylin and eosin sections; perineural invasion (PNI); seminal vesicle invasion (SVI) and lymph node metastasis (N). Patients were staged according to the 2002 tumor-node-metastasis system and pathological evaluation was performed by two of three pathologists in a council system used at Toho University Sakura Medical Center.
BCR date was defined as the date on which postoperative serum concentration of PSA reached ≥0.2 ng/ml, with confirmation by second and third PSA test results on repeated measurements that were equal to or higher than prior PSA levels. If postoperative PSA did not decrease to ≤0.2 ng/ml, the date of surgery was defined as the BCR date (19) .
MSKCC nomogram
The MSKCC postoperative nomogram can predict the probability of early BCR-free status at 2 years following RP (15) . This nomogram incorporated the following variables: preoperative serum PSA, age at time of RP, pathological primary and secondary GS, RM, EPE, SVI and N.
JHU nomogram
The JHU postoperative nomogram can predict the probability of early BCR at 3 years following surgery (16) . This nomogram incorporated the following variables: preoperative serum PSA value, pathological GS and pathological stage (organ confined disease or non-organ confined disease).
Statistical analysis
Results are presented as median (range) or as mean ± standard deviation, as appropriate. First, to validate the nomogram externally, the c-index was estimated to calculate an unbiased measure of the ability of the nomogram to discriminate among patients (20) . Moreover, calibration plots of each nomogram were constructed, in which the x-axis represents the predicted probability of causespecific survival after 5 years and the y-axis represents the actual probability. Second, early BCR (within 2 years after RP)-specific predictors were examined using our validation datasets, which was used for the MSKCC nomogram (n = 174). The Kaplan-Meier method was used to estimate BCR-free survival following RP and log-rank testing was conducted to compare the significance of differences between curves. After variables were selected in univariate analyses, Cox proportional hazards regression analyses was performed to determine significant predictors for BCR after RP. These statistical analyses were carried out using R software (http://www. r-project.org/) and SPSS Statistics version 23 (IBM, Chicago, IL, USA). Values of P < 0.05 were considered statistically significant.
Results

External validation of two nomograms
Baseline characteristics of our patients are shown in Supplementary  Table 1 . Thirty-two of the 233 patients (13.7%) developed early BCR within 2 years after RP. Forty-six of 233 patients (19.7%) had early BCR within 3 years after RP. Kaplan-Meier curves of BCR after RP are shown in Supplementary figure.
Twenty-three (13.2%) of the 174 patients for whom the MSKCC nomogram was applied showed BCR within 2 years following RP. Clinical and pathological characteristics of patients for whom the MSKCC nomogram was applied are also listed in Supplementary Table 1 . The c-index describing the predictive accuracy of the MSKCC nomogram was 0.72 (95% confidence interval [CI]: 0.61-0.83) for our patients. Thirty-nine (24.4%) of the 160 patients for whom the JHU nomogram was applied developed BCR within 3 years following RP. Clinical and pathological characteristics of patients for whom the JHU nomogram was applied are also listed in Supplementary Table 1 . The c-index describing the predictive accuracy of JHU nomogram was 0.71 (95% CI: 0.61-0.81) for our patients.
Calibration plots were constructed for each nomogram. In the MSKCC nomogram, the actual probability of BCR-free status within 2 years after RP for our patients was higher than the predicted probability (Fig. 1A) . In the JHU nomogram, the actual probability of BCR within 3 years after RP was basically consistent with the predicted probability, as compared with the calibration plot of the MSKCC nomogram (Fig. 1B) .
Predictors for early BCR at 2 years after RP
We statistically analyzed 174 patients who did not lack any of the clinical and pathological factors and were followed-up for more than 2 years after RP. In univariate analyses, ≥pT3 (P = 0.002), RM (P < 0.001), EPE (P = 0.007), SVI (P = 0.013), ly (P = 0.001) and LVI (P = 0.014) were found to be significantly associated with early BCR. Multivariate analysis was performed using these significant variables with the exception of LVI in univariate analyses, because LVI overlapped with ly. Multivariate analysis identified RM (hazard ratio [HR]: 3.938; 95% CI: 1.497-10.362; P = 0.005) and ly (HR: 2.836; 95% CI: 1.122-7.169; P = 0.028) as significant predictors of early BCR after RP (Table 1) .
Discussion
Early BCR after RP is an unfavorable event for PC patients and is associated with early progression, distant metastasis and cancerspecific mortality (5, 7, 8) . Some nomograms have been developed to predict the individual probability of early BCR after RP (5,13-16), because it is very important for both clinicians and patients to comprehend the risk of early BCR in clinical practice. To the best of our knowledge, this study offers the first evidence that two web-based postoperative nomograms demonstrated fair performance (MSKCC nomogram c-index, 0.72; JHU nomogram c-index, 0.71) in a Japanese population. A prognostic model needs to be validated externally to confirm the predictive and discriminating accuracy in each population or institution, because different ethnicities or institutions might have an impact on the results (2, 17, 18) .
Higher accuracy in outcome prediction can be achieved using integrated systems that combine multiple independent prognostic variables, but incorporation of too many variables might lead to the model losing the benefit of convenience. In addition to the incorporation of simple variables into the two nomograms, ly might offer a significant predictor for early BCR after RP. The suggestion has also been made that ly represents an important pathological parameter and significant predictor of shortened progression-free survival along with N in PC (14, 21, 22) .
LVI including ly was also significantly associated with early BCR after RP in this study. Since discriminating between ly and v is difficult, LVI is defined as the presence of cancer cells within an arterial, venous or lymphatic lumen on routine hematoxylin and eosin sections. Many researchers have recently reported LVI as a significant independent predictor of BCR after RP (23-31). Huang et al. evaluated the prognostic value of LVI in RP in a meta-analysis of the published literature, including a total of 9503 patients (23) . LVI was found in 12.2% of RP specimens in that study (23) . In the present study, 27 of 233 patients (11.6%) had LVI, a rate similar to that in the meta-analysis. Huang et al. showed that the pooled HR was significant for the probability of BCR-free status (HR: 2.05; 95% CI: 1.64-2.56; P < 0.00001) (23) . LVI therefore exhibited a detrimental effect on BCR-free probability and clinicopathological features in RP specimens and was an independent prognostic factor for BCR. Although some studies have focused on the association between LVI and early BCR (within 5 years) after RP (23) (24) (25) (26) (27) (28) (29) (30) (31) , LVI is a pathological feature indicating that prognosis correlates with aggressive PC behavior, such as higher PSA, higher GS, higher T stage, positive pathological nodes and seminal vesicle involvement, finally resulting in early BCR after RP (23) (24) (25) (26) (27) (28) (29) (30) (31) . Even equivocal LVI showed similar associations with adverse pathological features and rate of BCR to that of definitive LVI (31) . As a result, LVI or ly, if the latter can be evaluated, could provide good candidates for predicting early BCR after RP. The predictive accuracies of both web-based nomograms were not particularly high in the Japanese population. Nomograms that incorporate LVI, which includes ly, will be able to predict early BCR after RP more accurately. Several limitations of the present study should be considered. First, central pathological review for RP specimens was not performed, although diagnosis by multiple pathologists is performed in daily clinical practice. Second, due to the small number of patients with lymph node metastasis in this study, these patients might not have been fully validated in both nomograms.
In conclusion, two web-based postoperative nomograms were found to offer fair predictive accuracy for early postoperative BCR in Japanese patients. Moreover, LVI including ly may represent a good predictor for early postoperative BCR and there is a possibility of improving the accuracy when incorporated into new nomograms.
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